Pfizer Axes Deal For Brain Cancer Vaccine, Leaves Partner Celldex In the Lurch
A brave face: Celldex execs say they are ready and able to take brain cancer vaccine CDX-110 into Phase III without a Big Pharma partner.
A brave face: Celldex execs say they are ready and able to take brain cancer vaccine CDX-110 into Phase III without a Big Pharma partner.